This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
Incivek and Victrelis are discussed in this podcast with host Jeremy Cox and Andrew Keaveny, medical director of liver transplantation at Mayo Clinic in Jacksonville.
No comments:
Post a Comment